Sorrento Therapeutics Inc
Change company Symbol lookup
Select an option...
SRNE Sorrento Therapeutics Inc
EBTC Enterprise Bancorp Inc
FSLY Fastly Inc
BNR Burning Rock Biotech Ltd
FCNKX Fidelity® Contrafund® Fund Class K
CAT Caterpillar Inc
POAGX PRIMECAP Odyssey Aggressive Growth Fund
VFIFX Vanguard Target Retirement 2050 Fund Investor Shares
CMCSA Comcast Corp
CUZ Cousins Properties Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Sorrento Therapeutics, Inc. is a clinical-stage and commercial biopharma company. The Company operates through two segments: Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next generation of cancer therapeutics. These modalities include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy (DAR-T), antibody-drug conjugates (ADC), as well as bispecific antibody approaches. Additionally, Sorrento Therapeutics segment also includes Sofusa, a drug delivery technology that delivers biologics directly into the lymphatic system to potentially achieve improved efficacy and fewer adverse effects than standard parenteral immunotherapy. The Scilex segment is organized around its non-opioid pain management operations.

Closing Price
$13.01
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
101,923,101
0

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, August 13, 2020
Thinking about buying stock in Sorrento Therapeutics, FAT Brands, BioCryst Pharmaceuticals, TOP Ships, or Tesla?

InvestorsObserver issues critical PriceWatch Alerts for SRNE, FAT, BCRX, TOPS, and TSLA. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

August 12, 2020
Sorrento to Take Action Against Hindenburg Research for Statements Believed Intended to Manipulate Stock Price

Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced today that it believes it has uncovered fraudulent attempts to manipulate the Company's stock. On August 11, 2020, it was reported that an organization calling itself "Hindenburg...(Globe Newswire)

Thinking about buying stock in Boxlight Corp, Trevi Therapeutics, Plug Power, Sorrento Therapeutics, or iBio Inc?

InvestorsObserver issues critical PriceWatch Alerts for BOXL, TRVI, PLUG, SRNE, and IBIO. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

August 10, 2020
Thinking about trading options or stock in Sorrento Therapeutics, Vaxart Inc, Mercadolibre, Uber Technologies, or Carnival Corp?

InvestorsObserver issues critical PriceWatch Alerts for SRNE, VXRT, MELI, UBER, and CCL. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

August 07, 2020
Thinking about buying stock in Lyft Inc, Heat Biologics, Canopy Growth Corp, Sorrento Therapeutics, or Delta Air Lines?

InvestorsObserver issues critical PriceWatch Alerts for LYFT, HTBX, CGC, SRNE, and DAL. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

August 05, 2020
Thinking about buying stock in Sorrento Therapeutics, Aerpio Pharmaceuticals, Horizon Therapeutics, Riot Blockchain, or Royal Caribbean Cruises?

InvestorsObserver issues critical PriceWatch Alerts for SRNE, ARPO, HZNP, RIOT, and RCL. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

August 04, 2020
Thinking about trading options or stock in Varian Medical Systems, Sorrento Therapeutics, T2 Biosystems, Ford Motor, or American Airlines?

InvestorsObserver issues critical PriceWatch Alerts for VAR, SRNE, TTOO, F, and AAL. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

August 03, 2020
Thinking about trading options or stock in Sorrento Therapeutics, Chegg Inc, Peloton Interactive, Eli Lilly, or Tesla?

InvestorsObserver issues critical PriceWatch Alerts for SRNE, CHGG, PTON, LLY, and TSLA. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Thinking about buying stock in American Airlines, Pinterest, Precipio, Allscripts Healthcare Solutions, or Sorrento Therapeutics?

InvestorsObserver issues critical PriceWatch Alerts for AAL, PINS, PRPO, MDRX, and SRNE. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

July 29, 2020
Thinking about buying stock in On Deck Capital, Tupperware Brands, Sorrento Therapeutics, American Airlines, or General Electric?

InvestorsObserver issues critical PriceWatch Alerts for ONDK, TUP, SRNE, AAL, and GE. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

Sorrento Announces License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva

Sorrento Therapeutics, Inc. (Nasdaq: SRNE) ("Sorrento") today announced it has entered into a licensing agreement with Columbia University ("Columbia") for the rights to a rapid, one-step diagnostic test that detects SARS-CoV-2 virus in as little as...(PR Newswire)

July 27, 2020
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE

New York, New York--(Newsfile Corp. - July 27, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sorrento Therapeutics, Inc. ("Sorrento")...(Newsfile)

SRNE Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Sorrento Therapeutics, Inc Shareholders With Losses Exceeding $250K of Class Action and Lead Plaintiff Deadline: July 27, 2020

New York, New York--(Newsfile Corp. - July 27, 2020) - Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Sorrento Therapeutics, Inc.("Sorrento" or "the Company") (NASDAQ: SRNE) and certain of...(Newsfile)

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRNE, CEMI and JCOM

NEW YORK, NY / ACCESSWIRE / July 27, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have...(Accesswire)

DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - July 27, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sorrento Therapeutics, Inc. (NASDAQ: SRNE) ("Sorrento" or "the...(Newsfile)

CLASS ACTION UPDATE for SRNE, CLNY and ERII: Levi and Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / July 27, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...(Accesswire)

July 24, 2020
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE

New York, New York--(Newsfile Corp. - July 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sorrento Therapeutics, Inc. ("Sorrento")...(Newsfile)

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRNE, CLNY and CCL

NEW YORK, NY / ACCESSWIRE / July 24, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Shareholders who purchased shares in the following...(Accesswire)

MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - July 24, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sorrento Therapeutics, Inc. (NASDAQ: SRNE) ("Sorrento" or "the...(Newsfile)

Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") and SmartPharm Therapeutics, Inc. ("SmartPharm") announced today the signing of a letter of intent for Sorrento to acquire SmartPharm, a gene-encoded therapeutics company developing non-viral...(PR Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.